Source: MedRobot; Editor: Sophia
Reprint Requirements: Please indicate the source of the article at the beginning of the text, and it can be reprinted directly.
On March 12, 2025, Johnson & Johnson announced that itsMonarch Quest Robotic-Assisted Bronchoscopy TechnologyHas been approved by the U.S. FDA.The latest advancement in this technology utilizes AI-driven algorithms and is compatible with GE Healthcare's OEC 3D mobile CBCT imaging system. Johnson & Johnson submitted a 510(k) application for FDA clearance of this technology in the fall of last year.# Approval Details
Monarch is on the marketThe First Robot-Assisted Bronchoscopy System, providing the ability to access the airway minimally invasively and perform visual inspections, assisting clinicians in biopsying suspicious lung nodules, and helping achieve early definitive diagnosis in lung cancer cases, allowing patients to receive treatment as soon as possible.
According to the company, the Monarch Quest platform is based on stability and precision, adoptingUnique intrathecal endoscope design and continuous vision technology。
Compared with traditional intermittent imaging (e.g., images can only be observed when the operation is paused), continuous visual technology provides uninterrupted image feedback, allowing doctors to maintain visualization during the procedure.See changes in the surgical site in real time, without the need to pause operations to capture images.
The software will alsoEnhanceNavigation FunctionAndIntraoperative 3D Imaging DataCombined, it is expected to improve the accuracy of lung nodule localization.In addition, Monarch Quest's AI navigation leverages Nvidia's full-stack accelerated computing platform, enhancing its real-time computational capabilities.260%, capable of running complex algorithms to improve accuracy.Previously, Johnson & Johnson reached an agreement with Nvidia on the application of artificial intelligence in surgical robots.Monarch's digital capabilities have now expanded from preoperative planning to AI-based intraoperative navigation.# Bronchoscopy Robot Monarch™ Platform
Monarch™ Platform byDoctor Workstation, Robotic Arm Cart, Control Handle, and Instrument AccessoriesComposition. On November 6, 2023, Johnson & Johnson Medical Technologies announced its MONARCH® Electronic Bronchoscope Navigation Control SystemApproved for marketing in China。
Product Features
Robotic Arm:The Monarch™ platform has two robotic arms, where the proximal arm drives the rotatable sheath and the distal arm controls the bronchoscope. The sheath can rotate up to 130° in any direction, and the bronchoscope can independently advance and rotate up to 180°.
- Integrated Innovation Technology:AppliedMultimodal Fusion Navigation of Optical Recognition, Dynamic Electromagnetic Guidance, and Endoscope Movement with Game-style Joystick ControlSuch innovative technologies, and verify these signals with CT-based airway maps to determine the final range of the bronchoscope tip position in the lungs.
- Controller Flexibility:The controller hasHigh Flexibility and Human-Centered Design,Allow operators to choose different operating postures and positions based on surgical needs and personal preferences.Helps improve the efficiency and comfort of the surgery, while enabling the operator to better adapt to complex surgical environments.
- Integrated Camera:Real-time visualization can significantly improve the precision and safety of surgery. Images provided by the camera help doctors determine the position and orientation of surgical tools (such as probes, catheters, biopsy forceps, etc.) within the body, allowing for real-time adjustments to the angle, depth, or position of the tools to achieve optimal operational results.

- Further:Approximately48%The nodule is located in the outer one-third of the lung.Traditional biopsy tools may have difficulty reaching these nodules.
Monarch SystemDesign of Telescopic Endoscope and SheathYesPerform operations separately, such as bending or adjusting angles, to accommodate complex anatomical structures.,Capable of redirecting the force during insertion through design,Advance further into the lungs, fine-tune the biopsy needle, and place it in different areas of the nodule.Monarch SystemCapable of driving a retractable, flexible mirrored channel under dual robotic arm control to reach deep lung lesions and enable precise manipulation with continuous visual assistance.Clinical data show that the navigation success rate of the Monarch system is 88%, the diagnostic rate is 77%, and the incidence of complications such as pneumothorax and bleeding is less than 1%.Recently, the team led by Professor Hu Yi from the Department of Oncology Medicine at the General Hospital of the People's Liberation Army completedThe First Case in Mainland ChinaMonarch Robotic Bronchoscopy for Lung Nodule Biopsy Combined with Microwave Ablation Integrated Procedure, which has opened a new path for the diagnosis and treatment of complex pulmonary nodules.Aleksandra Popovic, President of Johnson & Johnson Medical Technologies' Monarch Division, stated: "The goal of the Monarch platform is to transform the treatment paradigm for diseases such as lung cancer. Monarch Quest reflects our commitment to delivering meaningful innovation to help clinicians enhance patient care.""Standard."
# MedRobot Recommended Articles CollectionChinese Surgical Robots (Listed Collection)
Well-known surgical robot manufacturers and upstream/downstream enterprises in ChinaSurgical Robotics Weekly ReportMore Dynamics of Surgical Robotics Companies